Suchergebnisse - "Zinzani, PierLuigi"

PubPharm (46)

1

ROSEWOOD : A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Zinzani, P. | Mayer, J. | Flowers, C. | +23

2

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia : an open-label, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lübbert, M. | Wijermans, P. | Kicinski, M. | +83

CommentIn: Lancet Haematol. 2023 Nov;10(11):e866-e867. - PMID 37914474

3

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

enthalten in: The New England journal of medicine | 2023

von Westin, J. | Oluwole, O. | Kersten, M. | +129

CommentIn: N Engl J Med. 2023 Sep 21;389(12):1152-1153. - PMID 37733322

4

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

enthalten in: Blood advances | 2022

von Savage, K. | Horwitz, S. | Advani, R. | +21

5

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

enthalten in: The New England journal of medicine | 2022

von Locke, F. | Miklos, D. | Jacobson, C. | +129

CommentIn: N Engl J Med. 2022 Feb 17;386(7):692-696. - PMID 34904797

6

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma

enthalten in: Leukemia | 2022

von Rossi, A. | Orecchioni, S. | Falvo, P. | +18

7

Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial

enthalten in: Leukemia & lymphoma | 2021

von Horwitz, S. | Zinzani, P. | Bagot, M. | +7

8

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma : final data

enthalten in: Blood advances | 2021

von Horwitz, S. | Scarisbrick, J. | Dummer, R. | +23

9

Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Matasar, M. | Dreyling, M. | Leppä, S. | +6

10

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD : final results of FIL HD0801 trial

enthalten in: Blood advances | 2021

von Ricardi, U. | Levis, M. | Evangelista, A. | +26

1
2
3
4
5
Nächster »
[5]